Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Study finds worse survival rates for heart failure despite advances in treatment

A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.

4 May 2017

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis’ PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.

3 May 2017

NUS researchers develop novel dual-mode contrast agent for better liver cancer imaging

Scientists from the National University of Singapore have developed a novel nanodiamond-based contrast agent - a chemical "dye" used to enhance the visibility of internal body structures in magnetic resonance imaging - that improves visualization of liver cancer tumors

2 May 2017

Combination therapy may be effective option for treating some women with ovarian cancer

Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer -- the most common subtype of ovarian cancer -- after standard treatment with the chemotherapy drug carboplatin.

2 May 2017

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a large study conducted by Roswell Park Cancer Institute researchers and published online ahead of print in the journal Gynecologic Oncology.

26 Apr 2017

Second cancers are far deadlier in younger people than older adults

Second cancers in children and adolescents and young adults are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.

20 Apr 2017

Researcher aims to eliminate chemotherapy-resistant ovarian tumors using virus treatment

In some cases, the Lassa virus starts with a fever and general weakness, moving toward headache, muscle pain, possible facial swelling, deafness, and worse. About 15 percent of patients hospitalized with severe cases die.

20 Apr 2017

NCCN Radiation Therapy Compendium adds nine new clinical practice guidelines in oncology

The National Comprehensive Cancer Network continues to build its NCCN Radiation Therapy Compendium with the publication of radiation therapy (RT) recommendations from an additional nine NCCN Clinical Practice Guidelines in Oncology

19 Apr 2017

Hypertension linked to better outcomes for subset of ovarian cancer patients

Hypertension, or high blood pressure, may come with a plus side, at least for a subset of women with ovarian cancer.

17 Apr 2017

Research finds diagnostic tests to be less accurate for children with impaired kidney function

Breaking research published today in AACC's Journal of Applied Laboratory Medicine reveals that a number of diagnostic tests are less accurate when performed in pediatric patients with impaired kidney function.

17 Apr 2017

Research finding could offer new way to fight deadly pancreatic cancer

Pancreatic cancer, most frequently pancreatic ductal adenocarcinoma (PDAC), is the most lethal and aggressive of all cancers. Unfortunately, there are not many effective therapies available other than surgery, and that is not an option for many patients.

10 Apr 2017

MIT engineers develop more sensitive approach to reveal ovarian tumors

Most ovarian cancer is diagnosed at such late stages that patients' survival rates are poor. However, if the cancer is detected earlier, five-year survival rates can be greater than 90 percent.

10 Apr 2017

Genomic Analysis Technologies: Past, Present and Future

In this interview, Jay Flatley, Executive Chairman of Illumina, gives an introduction to Illumina and the next generation genomics tools they provide.

From Pittcon 10 Apr 2017

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Fred Hutchinson Cancer Research Center immunotherapy researchers Drs. Kristin Anderson and Philip Greenberg and their colleagues are working on ways to tweak their team's early successes with T-cell therapy for leukemia to apply to solid tumors.

5 Apr 2017

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

A team led by researchers from the Stanford University School of Medicine has demonstrated a way to diagnose cancer without resorting to surgery, raising the possibility of far fewer biopsies.

5 Apr 2017

Researchers identify biomarker for likely aggressive, early-stage breast cancers

The one-size-fits-all approach to early stage breast cancer creates a paradox: Millions of dollars are spent on unnecessary surgeries and radiation to treat women with low-risk 'in situ' lesions, an estimated 85% of which would never progress to invasive cancers.

4 Apr 2017

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive.

3 Apr 2017

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Novocure announced today results from its phase 2 pilot INNOVATE trial studying Tumor Treating Fields (TTFields) in combination with weekly paclitaxel for the treatment of recurrent ovarian cancer.

31 Mar 2017

Researchers explore factors that influence patient's intent to get colorectal cancer screening

A patient's confidence in their ability to schedule, plan for and properly conduct their part in colorectal screening methods is a key factor that predicts whether they intend to be tested, according to new research from Penn State College of Medicine. The findings suggest that educating patients could improve screening rates.

30 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Study finds worse survival rates for heart failure despite advances in treatment

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

NUS researchers develop novel dual-mode contrast agent for better liver cancer imaging

Combination therapy may be effective option for treating some women with ovarian cancer

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

Second cancers are far deadlier in younger people than older adults

Researcher aims to eliminate chemotherapy-resistant ovarian tumors using virus treatment

NCCN Radiation Therapy Compendium adds nine new clinical practice guidelines in oncology

Hypertension linked to better outcomes for subset of ovarian cancer patients

Research finds diagnostic tests to be less accurate for children with impaired kidney function

Research finding could offer new way to fight deadly pancreatic cancer

MIT engineers develop more sensitive approach to reveal ovarian tumors

Genomic Analysis Technologies: Past, Present and Future

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Researchers identify biomarker for likely aggressive, early-stage breast cancers

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Researchers explore factors that influence patient's intent to get colorectal cancer screening

FDA approves new maintenance therapy for recurrent cancers

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in